Jynarque for patient T.H.
Ended Awarded
- Contract number
- 36C24621F0046
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,099
Award facts
- Contract value 100% obligated
- $10,099.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Richmond, VA 23249, USA
Award details come from SAM.gov/FPDS.
About this award
On November 3, 2020, the Department of Veterans Affairs' Veterans Integrated Service Network 6 (VISN 6) awarded a delivery order to Otsuka America Pharmaceutical Inc. for the supply of Jynarque (tolvaptan), a specialty pharmaceutical medication used to treat autosomal dominant polycystic kidney disease and hyponatremia. The contract, valued at $10,099.21, was awarded on a firm-fixed price basis with no set-aside designation and is scheduled for completion by November 6, 2020. Performance will take place in Richmond, Virginia. This delivery order falls under the larger Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle and is supported by Otsuka America Pharmaceutical Inc.'s substantial Indefinite Delivery Vehicle portfolio with the VA, including an $83.3M Blanket Purchase Agreement for Jynarque.
Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer headquartered in Rockville, Maryland, serves as the prime contractor on this award with no identified subcontractors. The company specializes in developing and distributing complex pharmaceutical products and has established itself as a primary supplier of specialty medications to the VA's Veterans Health Administration across multiple Integrated Service Networks. This delivery order represents part of the company's ongoing support to the VA's mission of providing critical pharmaceutical treatments to veterans nationwide, with Jynarque delivery orders consistently ranging from approximately $10,000 to $113,000 across various VA facilities and locations.
Quick answers
Who was awarded contract 36C24621F0046?
36C24621F0046 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on November 3, 2020.
How much is contract 36C24621F0046 worth?
The government has obligated $10,099 on 36C24621F0046.
Is contract 36C24621F0046 an order under another contract?
Yes. 36C24621F0046 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24621F0046 competed?
The extent of competition for 36C24621F0046 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award